X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1814) 1814
Publication (255) 255
Book Review (28) 28
Book Chapter (15) 15
Book / eBook (4) 4
Conference Proceeding (2) 2
Dissertation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1264) 1264
frontotemporal dementia (1194) 1194
index medicus (1151) 1151
neurosciences (867) 867
dementia (836) 836
clinical neurology (733) 733
male (716) 716
alzheimer's disease (715) 715
female (711) 711
aged (643) 643
middle aged (618) 618
alzheimers-disease (594) 594
frontotemporal lobar degeneration (572) 572
diagnosis (369) 369
neurology (359) 359
biomarkers (338) 338
mild cognitive impairment (311) 311
cerebrospinal fluid (309) 309
psychiatry (303) 303
magnetic resonance imaging (287) 287
neurodegenerative diseases (283) 283
amyotrophic-lateral-sclerosis (272) 272
pathology (269) 269
mutation (265) 265
amyotrophic lateral sclerosis (261) 261
tau (250) 250
aged, 80 and over (246) 246
brain (242) 242
neurodegeneration (239) 239
dementia disorders (228) 228
cerebrospinal-fluid (226) 226
mental disorders (226) 226
atrophy (212) 212
brain - pathology (209) 209
geriatrics & gerontology (209) 209
neuroimaging (206) 206
alzheimer disease - diagnosis (205) 205
neuropsychological tests (205) 205
biomarkers - cerebrospinal fluid (203) 203
nervous system diseases (196) 196
proteins (196) 196
research (196) 196
animals (195) 195
alzheimer disease - cerebrospinal fluid (187) 187
alzheimers disease (185) 185
article (184) 184
disease (183) 183
degeneration (179) 179
adult (178) 178
progressive supranuclear palsy (176) 176
tau proteins - cerebrospinal fluid (173) 173
genetic aspects (162) 162
diagnosis, differential (152) 152
alzheimer’s disease (151) 151
lewy bodies (151) 151
analysis (148) 148
alzheimer disease - pathology (146) 146
cognitive ability (142) 142
lobar degeneration (139) 139
amyloid beta-peptides - cerebrospinal fluid (133) 133
dementia - diagnosis (128) 128
tau protein (128) 128
frontotemporal dementia - diagnosis (127) 127
biomarker (125) 125
disease progression (125) 125
progranulin (124) 124
behavioral variant (123) 123
diagnostic-criteria (121) 121
frontotemporal dementia - genetics (119) 119
risk factors (118) 118
frontotemporal dementia - pathology (117) 117
aphasia (114) 114
tdp-43 (111) 111
semantic dementia (110) 110
criteria (109) 109
neuroscience (109) 109
medicine & public health (107) 107
patients (107) 107
vascular dementia (106) 106
mri (105) 105
physiological aspects (104) 104
nervous system (103) 103
biochemistry & molecular biology (102) 102
corticobasal degeneration (102) 102
primary progressive aphasia (101) 101
tau proteins - metabolism (101) 101
care and treatment (100) 100
development and progression (100) 100
parkinsons-disease (100) 100
peptide fragments - cerebrospinal fluid (99) 99
memory (95) 95
tau proteins - genetics (95) 95
medical imaging (94) 94
medical research (93) 93
genetics (92) 92
csf biomarkers (91) 91
neurons (91) 91
alzheimer disease - genetics (89) 89
mutations (89) 89
studies (89) 89
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1794) 1794
German (19) 19
French (8) 8
Spanish (4) 4
Czech (3) 3
Japanese (3) 3
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA Neurology, ISSN 2168-6149, 03/2019, Volume 76, Issue 3, pp. 318 - 325
IMPORTANCE Neuronal and axonal destruction are hallmarks of neurodegenerative diseases, but it is difficult to estimate the extent and progress of the damage... 
BIOMARKERS | CRITERIA | DIAGNOSIS | ALZHEIMERS-DISEASE | FRONTOTEMPORAL DEMENTIA | CSF | SENSITIVITY | AMYOTROPHIC-LATERAL-SCLEROSIS | NEURODEGENERATIVE DISEASES | SEVERITY | CLINICAL NEUROLOGY | Frontotemporal Dementia - cerebrospinal fluid | Parkinsonian Disorders - cerebrospinal fluid | Humans | Middle Aged | Parkinsonian Disorders - diagnosis | Dementia - diagnosis | Male | Intermediate Filaments - metabolism | Case-Control Studies | Alzheimer Disease - diagnosis | Neurofilament Proteins - cerebrospinal fluid | Parkinson Disease - cerebrospinal fluid | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Cognition - physiology | Dementia - cerebrospinal fluid | Female | Cognitive Dysfunction - diagnosis | tau Proteins - cerebrospinal fluid | Cognitive Dysfunction - cerebrospinal fluid | Motor Neuron Disease - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Frontotemporal Dementia - diagnosis | Parkinson Disease - diagnosis | Aged | Biomarkers - cerebrospinal fluid | Motor Neuron Disease - diagnosis | Brain | Parkinson's disease | Cognitive ability | Disorders | Impairment | Cognition | Cerebrospinal fluid | Proteins | Motor neuron diseases | Autopsy | Neurodegeneration | Dementia disorders | Degeneration | Paralysis | Light levels | Alzheimer's disease | Movement disorders | Autopsies | Neurodegenerative diseases | Motor neurone disease | Amyotrophic lateral sclerosis | Disease control | Lewy bodies | Diseases | Neurological diseases | Cognition & reasoning | Tau protein | Progressive supranuclear palsy | Correlation analysis | β-Amyloid | Frontotemporal dementia | Dementia | Neurosciences | Neurovetenskaper
Journal Article
Movement Disorders, ISSN 0885-3185, 07/2011, Volume 26, Issue 8, pp. 1428 - 1435
Journal Article
EMBO Molecular Medicine, ISSN 1757-4676, 07/2017, Volume 9, Issue 7, pp. 859 - 868
Journal Article
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 06/2018, Volume 14, Issue 6, pp. 751 - 763
Journal Article
Journal Article
Journal of Alzheimer's disease : JAD, ISSN 1387-2877, 2014, Volume 42, Issue 1, pp. 157 - 167
Journal Article
JAMA Neurology, ISSN 2168-6149, 06/2019, Volume 76, Issue 9, pp. 1035 - 1048
Journal Article
Acta Neuropathologica, ISSN 0001-6322, 7/2012, Volume 124, Issue 1, pp. 23 - 35
The effects of applying clinical versus neuropathological diagnosis and the inclusion of cases with coincident neuropathological diagnoses have not been... 
Pathology | Neurosciences | Biomarker | Amyloid beta | Medicine & Public Health | Alzheimer’s disease | Frontotemporal lobar degeneration | Tau | Cerebrospinal fluid | Alzheimer's disease | DNA-BINDING | PATHOLOGY | ALZHEIMERS ASSOCIATION WORKGROUPS | CEREBROSPINAL-FLUID | NEUROSCIENCES | CLINICAL NEUROLOGY | NATIONAL INSTITUTE | P-TAU | A-BETA | DIAGNOSTIC-CRITERIA | LEWY BODIES | CORTICOBASAL DEGENERATION | Frontotemporal Dementia - cerebrospinal fluid | Frontotemporal Lobar Degeneration - pathology | Frontotemporal Lobar Degeneration - cerebrospinal fluid | Peptide Fragments - cerebrospinal fluid | Enzyme-Linked Immunosorbent Assay | Area Under Curve | Humans | Middle Aged | Male | tau Proteins - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Alzheimer Disease - pathology | Psychiatric Status Rating Scales | Analysis of Variance | Amyotrophic Lateral Sclerosis - cerebrospinal fluid | Sensitivity and Specificity | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Female | Aged | Biomarkers - cerebrospinal fluid | Frontotemporal Dementia - pathology | Neurodegenerative diseases | Lewy body disease | biomarkers | Amyotrophic lateral sclerosis | Data processing | beta -Amyloid | Lewy bodies | Tau protein | Classification | Dementia disorders | Frontotemporal dementia | Enzyme-linked immunosorbent assay
Journal Article